Graft Survival After Penetrating and Endothelial Keratoplasty in Iridocorneal Endothelial Syndrome.
Descemet Stripping Endothelial Keratoplasty
/ methods
Endothelium, Corneal
/ transplantation
Female
Follow-Up Studies
Fuchs' Endothelial Dystrophy
/ diagnosis
Graft Rejection
/ epidemiology
Graft Survival
Humans
Incidence
Iridocorneal Endothelial Syndrome
/ diagnosis
Keratoplasty, Penetrating
/ methods
Male
Middle Aged
Registries
Retrospective Studies
Risk Factors
Time Factors
Treatment Outcome
United Kingdom
/ epidemiology
Visual Acuity
Journal
Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
pubmed:
25
7
2019
medline:
2
6
2020
entrez:
24
7
2019
Statut:
ppublish
Résumé
To compare the survival of a first penetrating keratoplasty (PK) or endothelial keratoplasty (EK) for iridocorneal endothelial (ICE) syndrome with transplant survival in Fuchs endothelial dystrophy (FED) and pseudophakic bullous keratopathy (PBK). We compared graft survival of PK and EK for ICE syndrome for 2 time periods. We then compared graft survival in ICE syndrome with graft survival in FED and PBK. Kaplan-Meier estimates of graft survival up to 5 years posttransplant were calculated with 95% confidence intervals (CI), whereas comparisons between the groups were performed using the log-rank test. We included 86 first transplants for ICE syndrome. There was no difference in graft survival between the 58 PKs and the 28 EKs for up to 5 years after surgery (P = 0.717). For the period from 2009 to 2017, the 5-year graft survival rates for ICE syndrome were 64.3% (CI, 21.8%-88.0%) for the 16 PKs and 66.8% (CI, 41.8%-83.0%) for the 26 EKs (P = 0.469). Between 2009 and 2017, the 5-year survival rate for 42 grafts with ICE syndrome was 62.7% (CI, 39.6%-79.0%), which was lower than 75.9% (CI, 74.2%-77.4%) in 7058 transplants for FED but higher than 55.1% (CI, 52.0%-58.0%) in 3320 transplants for PBK, although the numbers of ICE transplants are too small to tell whether this difference was by chance. The results indicate no difference in graft survival between PK and EK for ICE syndrome. Graft survival in ICE syndrome is intermediate between that of FED and PBK.
Identifiants
pubmed: 31335531
doi: 10.1097/ICO.0000000000002039
pii: 00003226-202001000-00005
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
18-22Références
Silva L, Najafi A, Suwan Y, et al. The iridocorneal endothelial syndrome. Surv Ophthalmol. 2018;63:665–676.
Hemady RK, Patel A, Blum S, et al. Bilateral iridocorneal endothelial syndrome: case report and review of the literature. Cornea. 1994;13:368–372.
Chandran P, Rao HL, Mandal AK, et al. Glaucoma associated with iridocorneal endothelial syndrome in 203 Indian subjects. PLoS One. 2017;12:e0171884.
Teekhasaenee C, Ritch R. Iridocorneal endothelial syndrome in Thai patients: clinical variations. Arch Ophthalmol. 2000;118:187–192.
Shields MB, Campbell DG, Simmons RJ. The essential iris atrophies. Am J Ophthalmol. 1978;85:749–759.
Feng B, Tang X, Chen H, et al. Unique variations and characteristics of iridocorneal endothelial syndrome in China: a case series of 58 patients. Int Ophthalmol. 2018;38:2117–2126.
Yanoff M. Iridocorneal endothelial syndrome: unification of a disease spectrum. Surv Ophthalmol. 1979;24:1–2.
Kidd M, Hetherington J, Magee S. Surgical results in iridocorneal endothelial syndrome. Arch Ophthalmol. 1988;106:199–201.
Wilson MC, Shields MB. A comparison of the clinical variations of the iridocorneal endothelial syndrome. Arch Ophthalmol. 1989;107:1465–1468.
Alvim PT, Cohen EJ, Rapuano CJ, et al. Penetrating keratoplasty in iridocorneal endothelial syndrome. Cornea. 2001;20:134–140.
Chen J, Liu Z, Yu L. Corneal endothelial decompensation of iridocorneal endothelial syndrome treated by penetrating keratoplasty [in Chinese]. Zhonghua Yan Ke Za Zhi. 1996;32:264–266.
Crawford GJ, Stulting RD, Cavanagh HD, et al. Penetrating keratoplasty in the management of iridocorneal endothelial syndrome. Cornea. 1989;8:34–40.
DeBroff BM, Thoft RA. Surgical results of penetrating keratoplasty in essential iris atrophy. J Refract Corneal Surg. 1994;10:428–432.
Fajgenbaum MA, Hollick EJ. Descemet stripping endothelial keratoplasty in iridocorneal endothelial syndrome: postoperative complications and long-term outcomes. Cornea. 2015;34:1252–1258.
Price MO, Price FW. Descemet stripping with endothelial keratoplasty for treatment of iridocorneal endothelial syndrome. Cornea. 2007;26:493–497.
Ao M, Feng Y, Xiao G, et al. Clinical outcome of Descemet stripping automated endothelial keratoplasty in 18 cases with iridocorneal endothelial syndrome. Eye (Lond). 2018;32:679–686.
Chaurasia S, Ramappa M, Garg P, et al. Endothelial keratoplasty in the management of irido-corneal endothelial syndrome. Eye (Lond). 2013;27:564–566.
Huang T, Wang Y, Ji J, et al. Deep lamellar endothelial keratoplasty for iridocorneal endothelial syndrome in phakic eyes. Arch Ophthalmol. 2009;127:33–36.
Weller JM, Tourtas T, Kruse FE. Feasibility and outcome of Descemet membrane endothelial keratoplasty in complex anterior segment and vitreous disease. Cornea. 2015;34:1351–1357.
Ziaei M, Gokul A, Patel DV, et al. Descemet membrane endothelial keratoplasty for treatment of iridocorneal endothelial syndrome. Can J Ophthalmol. 2018;53:e226–e229.
Buxton JN, Lash RS. Results of penetrating keratoplasty in the iridocorneal endothelial syndrome. Am J Ophthalmol. 1984;98:297–301.
Chang PC, Soong HK, Couto MF, et al. Prognosis for penetrating keratoplasty in iridocorneal endothelial syndrome. Refract Corneal Surg. 1993;9:129–132.
Quek DT, Wong CW, Wong TT, et al. Graft failure and intraocular pressure control after keratoplasty in iridocorneal endothelial syndrome. Am J Ophthalmol. 2015;160:422–429.e1.
Levy SG, Kirkness CM, Moss J, et al. The histopathology of the iridocorneal-endothelial syndrome. Cornea. 1996;15:46–54.
Park CY, Lee JK, Gore PK, et al. Keratoplasty in the United States: a 10-year review from 2005 through 2014. Ophthalmology. 2015;122:2432–2442.
Chaurasia S, Ramappa M, Sangwan VS. Clinical outcomes of non-Descemet stripping automated endothelial keratoplasty. Int Ophthalmol. 2012;32:571–575.
Coster DJ, Lowe MT, Keane MC, et al. A comparison of lamellar and penetrating keratoplasty outcomes: a registry study. Ophthalmology. 2014;121:979–987.
Greenrod EB, Jones MN, Kaye S, et al. Center and surgeon effect on outcomes of endothelial keratoplasty versus penetrating keratoplasty in the United Kingdom. Am J Ophthalmol. 2014;158:957–966.
Ang M, Soh Y, Htoon HM, et al. Five-year graft survival comparing Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty. Ophthalmology. 2016;123:1646–1652.
Stewart RM, Jones MN, Batterbury M, et al. Effect of glaucoma on corneal graft survival according to indication for penetrating keratoplasty. Am J Ophthalmol. 2011;151:257–262.e1.
Anshu A, Price MO, Price FW. Descemet's stripping endothelial keratoplasty: long-term graft survival and risk factors for failure in eyes with preexisting glaucoma. Ophthalmology. 2012;119:1982–1987.
Alvarado JA, Underwood JL, Green WR, et al. Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol. 1994;112:1601–1609.
Hirst LW, Quigley HA, Stark WJ, et al. Specular microscopy of irido-corneal endothelial syndrome. Aust J Ophthalmol. 1980;8:139–146.
Laganowski HC, Kerr Muir MG, Hitchings RA Glaucoma and the iridocorneal endothelial syndrome. Arch Ophthalmol. 1992;110:346–350.